Facebook
Twitter
LinkedIn
ForwardMayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2020 - LIVESTREAM
Course Directors: Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., and
Dan G. Duda, D.M.D., Ph.D.
November 13-14, 2020 - Livestream!
Course Description
At this livestreamed CME course, nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-pancreatico-biliary cancers. Through didactic lectures, case presentations, panel discussions and Q&A, faculty present information that learners can immediately implement into daily clinical practice. Topics include the importance of early diagnosis and treatment considerations, including surgery, radiation, locoregional approaches, and systemic therapies. Attendees have ample opportunity to connect and interact with peers and faculty.
| Registration Fee | |
|---|---|
| M.D., D.O., Ph.D. | $300 |
| Allied Health, NP, PA, Retirees | $285 |
| Students, Residents, Fellows | $150 |
* A limited number of scholarships are available. Please contact prewitt.whitney@mayo.edu with questions.
 | In collaboration with the International Association |
Target Audience
This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, physician assistants, nurse practitioners, registered nurses, oncology pharmacists, oncology nurses and clinical research personnel. Specialties include: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Identify current and emerging strategies for early diagnosis and surveillance of liver cancer
- Identify patients suitable for a liver transplant.
- Integrate novel molecularly-targeted, as well as immune-based, therapeutic strategies in clinical care and clinical trial participation
- Describe molecular biology of pancreatic, liver and biliary cancers
- Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer
- Describe the latest state of the science in pancreatic cancer, liver and biliary cancer
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Click here to view Program Schedule on mobile
COURSE DIRECTORS
Tanios S. Bekaii-Saab, M.D.
Mitesh J. Borad, M.D.
Mayo Clinic
Phoenix, Arizona
Dan G. Duda, D.M.D., Ph.D.
Massachusetts General Hospital
Boston, Massachusetts
GUEST FACULTY
Ghassan K. Abou-Alfa, M.D., M.B.A.
Memorial Sloan Kettering Cancer Center
New York, New York
Nilofer S. Azad, M.D.
Johns Hopkins
Baltimore, Maryland
Prof. John Bridgewater
University College London Hospitals
London, England
Anthony B. El-Khoueiry, M.D.
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California
Bassel El-Rayes, M.D.
Emory University
Atlanta, Georgia
Richard S. Finn, M.D.
Ronald Reagan UCLA Medical Center
Santa Monica, California
Lipika Goyal, M.D., M.Phil
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
Abhinav Humar, M.D.
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Andrew H. Ko, M.D., FASCO
Helen Diller Family Comprehensive Cancer Center
University of California
San Francisco, California
Sunyoung S. Lee, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, Texas
David C. Madoff, M.D.
Yale School of Medicine
Smilow Cancer Hospital Care Center
North Haven, Connecticut
Satdarshan (Paul) Singh Monga, M.D.
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Eileen M. O’Reilly, M.D.
Memorial Sloan Kettering Cancer Center
New York, New York
Rachna T. Shroff, M.D., M.S.
University of Arizona Cancer Center
Tucson, Arizona
MAYO CLINIC FACULTY
Daniel H. Ahn, D.O.
Sadeer J. Alzubaidi, M.D.
Jonathan B. Ashman, M.D., Ph.D.
Christopher (Chris) L. Hallemeier, M.D.
David M. Chascsa, M.D.
Wen Wee Ma, M.B.B.S.
Amit K. Mathur, M.D., M.S., FACS
Robert R. McWilliams, M.D.
Kabir Mody, M.D.
Adyr A. Moss, M.D.
Lewis R. Roberts, M.B., Ch.B., Ph.D.
Chee-Chee Stucky, M.D.
Mark J. Truty, M.D., M.S.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 8 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 8 AOA Category 2-A credits.
ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared with ABIM through PARS.
Other Healthcare Professionals
A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Daily Breakdown for days of General Session:
Friday: 4 AMA/Attendance, 4 ANCC, 4 AOA
Saturday: 4 AMA/Attendance, 4 ANCC, 4 AOA
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 8.00 ABIM
- 8.00 AMA PRA Category 1 Credit™
- 8.00 ANCC
- 8.00 AOA Category 2-A
- 8.00 Attendance
VIRTUAL EXHIBIT HALL OPPORTUNITY
This course offers the unique opportunity for companies to interact with health care providers via a Virtual Exhibit Hall. Analogous to booths at scientific conferences, this is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors.
If you are interested in becoming an exhibitor, please email Kristy Badder.
| Exhibitors - Click on Exhibitor Logo to Access the Virtual Booth | ||
|---|---|---|
AbbVie Medical Affairs: Hepatology
|
AbbVie Medical Affairs: Pancreatology |
|
|
|  |
|  |
|
|
|
|
|
Exhibitor Information Removed per Vendor Request. |
|
The Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.
Price
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.